Cyclic AMP is a global virulence regulator governing inter and intrabacterial signalling in Acinetobacter baumannii
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012529 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Lyuboslava G Harkova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Antimicrobial Innovations Centre, Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London…. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Cyclic AMP, Biofilms, Signal Transduction. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, British Heart Foundation/Diabetes UK, Medical Research Council.
Abstract (Originalsprache)
Acinetobacter baumannii is an opportunistic nosocomial pathogen with high morbidity and mortality rates. Current treatment options for this pathogen are limited due to its increasing resistance to last-resort antibiotics. Despite A . baumannii’s leading position in the World Health Organisations priority pathogens list, little is known about its virulence regulation. Through a high-throughput screening approach to identify novel biofilm regulators, we identified a previously uncharacterised predicted adenylate cyclase (AC), CavA, as a central regulator of this phenotype. cAMP is a crucial mediator of various aspects of bacterial physiology in other species but information about its role in A . baumannii is limited. We confirm that CavA AC is functional and synthesizes cAMP in A . baumannii . Using dRNA-seq, we verify that CavA is a negative biofilm formation regulator affecting Csu pili and exopolysaccharide production. We demonstrate for the first time that in A . baumannii , cAMP is atop of a hierarchical signalling cascade controlling inter- and intrabacterial signalling by modulating quorum sensing and cyclic di-GMP systems, ultimately governing virulence in vivo and adaptive antibiotic resistance. In contrast to the well-established paradigm in other bacteria where cAMP and cyclic di-GMP levels are inversely regulated, we uncover that the levels of these second messengers are directly proportional in A . baumannii . Overall, this study uncovers the central role of CavA and cAMP in the pathogenic success of A . baumannii and highlights this signalling cascade as a high potential target for novel therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Antimicrobial Innovations Centre, Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom.
- Centro Andaluz de Biología del Desarrollo (CABD-CSIC-JA), Universidad Pablo de Olavide, Sevilla, Spain.
ORCID-Profile: Ronan R McCarthy
Förderung
- Biotechnology and Biological Sciences Research Council
- British Heart Foundation/Diabetes UK
- Medical Research Council
- Academy of Medical Sciences
- Agencia Estatal de Investigación
Zitieren
APA
Harkova, L. G., de Dios, R., Rubio-Valle, A., Pérez-Pulido, A. J., & McCarthy, R. R. (2024). Cyclic AMP is a global virulence regulator governing inter and intrabacterial signalling in Acinetobacter baumannii. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012529
Vancouver
Harkova LG, de Dios R, Rubio-Valle A, Pérez-Pulido AJ, McCarthy RR. Cyclic AMP is a global virulence regulator governing inter and intrabacterial signalling in Acinetobacter baumannii. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012529
BibTeX
@article{Harkova2024,
author = {Harkova, Lyuboslava G and de Dios, Rubén and Rubio-Valle, Alejandro and Pérez-Pulido, Antonio J and McCarthy, Ronan R},
title = {Cyclic AMP is a global virulence regulator governing inter and intrabacterial signalling in Acinetobacter baumannii},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012529}
}
EUVIMED